Will the Covid vaccine help the world go back to normal?
Israel leads the world in vaccinations per capita, so what has the country learned? Join ISRAEL21c for a discussion with two leading experts in the field.
Israel leads the world in vaccinations per capita, so what has the country learned? Join ISRAEL21c for a discussion with two leading experts in the field.
Study of 1.2m people shows Pfizer-BioNTech vaccine 94% effective in preventing symptomatic Covid-19 and 92% effective in averting serious cases.
Israeli study of vaccinated healthcare workers warns doctors to test people complaining of post-vaccination symptoms because they could be infected.
Strong immune response detected regardless of duration between infection and vaccination, and regardless of ethnicity.
New Israeli study bolsters emerging evidence that Pfizer-BioNTech vaccine protects those who are immunized and those around them from Covid-19.
Findings indicate vaccination cuts risk of infecting others, reducing viral load by 1.6 to 20 times in vaccinated individuals who are Covid positive.
Israel’s extraordinary vaccination program has provided a wealth of information about the Pfizer-BioNTech vaccine and its impact.
Blood tests on 102 fully vaccinated healthcare workers in Israel show level of antibodies higher than in patients who recovered from Covid-19.
Study of 800,000 Covid test takers, half inoculated with the first dose and half not, shows no difference in infection rate until two weeks later.
The Daily Mail takes a look at why Israel has managed to pull further ahead than any other nation in the world in the race to vaccinate citizens.
Within 12 days, Israel managed to vaccinate one million citizens, outstripping every other country in the world. Watch here to discover the secret to our success.
Data shows that Israel was among fastest in rolling out the first dose of the Pfizer/BioNTech vaccine to healthcare workers and people over 60.
Dr. Tal Zaks says if the US company’s experimental vaccine receives FDA approval, some of the first doses will go to Israel as agreed upon last June.
Testing of BriLife vaccine developed at Israel Institute for Biological Research begins at Hadassah and Sheba medical centers on healthy volunteers.
Three Israeli doctors examine label changes on vaccines that entered the market in the past 20 years, confirming there’ve been few significant issues.